Italfarmaco Provides Givinostat Update (January 2018) Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 7 years ago You may also like 1:02:48 Connect with the Experts: Cardiac Care & Research (February 27, 2020) 5 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 29:46 Update on Investigational Suvodirsen in Duchenne Muscular Dystrophy (December 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 1:17:48 Better Todays. Stronger Tomorrows. (December 2019) 5 years ago Care Webinars,Research & Clinical Trial Webinars,Webinars 35:37 NS Pharma Provides Viltolarsen Update (November 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 47:13 DYSTANCE 51, a Phase 2/3 Clinical Trial of Investigational Suvodirsen in Duchenne (October 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 52:44 Community Discussion with Sarepta Therapeutics (August 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 18:32 Adaptive Sports (August 2019) 5 years ago For Teens & Adults,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 57:50 Capricor’s HOPE-2 Interim Analysis (July 2019) 5 years ago Research & Clinical Trial Webinars,Webinars «1…1213141516…25»Page 14 of 25
by: Parent Project Muscular Dystrophy
